Immuron Share Price and Company Fundamentals
Last traded: Last Monday at 4:04 AM
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; ProIBS, an over the counter orally administered product containing the proprietary ingredient AVH200 for the treatment of irritable bowel syndrome; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops IMM-529, which is in Phase II clinical trial for the treatment of Clostridioides difficile infection. In addition, the company offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.
Key Metrics
PE ratio
-
PB ratio
0.97
Dividend yield
0.00%
Beta
0.47
Market cap
$10.98M
Enterprise value
$2.15M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Full time employees | 7 |
| Website | https://www.immuron.com.au |
| Mailing address | 62 Lygon Street Level 3 Carlton South Carlton VIC 3053 Australia |
| Phone / Fax | 61 3 8892 4854 / |
Dividends
More: Immuron Dividend history, yield and payout ratio
Dividend yield
0.00%
Dividend amount
$-
Payout ratio
-
5Y Avg. yield
-%
Immuron paid $- dividend and the ex-dividend date was -.The dividend payout ratio is -. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.
Company Executives
As of Nov 2026, following are the company executives and directors listed on Immuron.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Steven George Lydeamore CPA, M.B.A. | Chief Executive Officer | 57 | |
| Dr. Jerry Kanellos Ph.D. | Chief Scientific Officer | 64 | |
| Mr. Flavio Palumbo | Chief Commercial Officer | 51 | |
| Mr. Aaron Laurita | Chief Financial Officer | ||
| Mr. David Lyon | Head of Marketing | ||
| Ms. Olga Smejkalova | Company Secretary |
Profitability and management effectiveness
Profit margin
-47.71%
Operating margin
-46.23%
Return on assets
-19.14%
Return on equity
-38.27%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Immuron is 10.98M and its enterprise value is 2.15M. The enterprise value to revenue ratio of IMC is 0.28. The enterprise value to EBITDA ratio of IMC is -0.61.
The IMC's stocks Beta value is 0.47 making it 53% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Immuron (IMC)
Immuron (ASX:IMC) Frequently Asked Questions
1. What is Immuron's Stock Symbol?
Immuron trades on ASX under the ticker symbol "IMC".
2. What is Immuron's stock price today?
One share of IMC stock can currently be purchased for approximately $0.034.
3. How can I contact Immuron?
Immuron's mailing address is 62 Lygon Street Level 3 Carlton South Carlton VIC 3053 Australia. The company can be reached via phone at 61 3 8892 4854.
4. What is Immuron's official website?
The official website of Immuron is https://www.immuron.com.au.